Gastrointestinal (GI) cancer is a term for the group of cancers that affect the digestive system. This includes cancers of the esophagus, gallbladder & biliary tract, liver, pancreas, stomach, small intestine, bowel (large intestine or colon and rectum), and anus.
Jump to Studies
Gastric, Esophageal and GEJ | Colorectal | Pancreatic | Liver
We have several clinical trials that are currently recruiting to evaluate experimental medications for gastrointestinal (GI) cancer. See if there are clinical trials that might be right for you.
Thank you for Considering a Clinical Trial
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).
Here are some options for you to find more information:
An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
View Trial DetailsAn Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
View Trial DetailsAn Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
View Trial DetailsA Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
View Trial DetailsAn Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread
An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
View Trial DetailsA Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
View Trial DetailsA Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
View Trial DetailsA Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
View Trial DetailsA Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
Get updates on clinical trials
Let us help you find a trial you might qualify for
Share your experiences and learn from others.
Visit Our Community
Read the stories below and send us your own.
"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...
"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...
View Story
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"
View Story
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"
View Story
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"
View StoryEsophageal cancer occurs when tumors form in the tissues of the esophagus, which is a muscular tube that moves food and liquids from the throat to the stomach for digestion.
Learn More
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer
Learn MoreThe signs & symptoms of gastric cancer can vary depending on the stage of the cancer. In general, symptoms may also be associated with other conditions. Talk to your doctor if you have any of these symptoms.
Learn More
Colorectal cancer, or CRC, is a cancer that forms in the tissues of the colon or rectum, which are part of the body’s digestive or gastrointestinal (GI) system.
Learn MoreBristol-Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol-Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.
